NDC 55111-469

Metoprolol succinate

Metoprolol Succinate

Metoprolol succinate is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is Metoprolol Succinate.

Product ID55111-469_610f213a-a956-71d0-8777-9de4096a607c
NDC55111-469
Product TypeHuman Prescription Drug
Proprietary NameMetoprolol succinate
Generic NameMetoprolol Succinate
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2012-09-10
Marketing CategoryANDA / ANDA
Application NumberANDA078889
Labeler NameDr. Reddy's Laboratories Limited
Substance NameMETOPROLOL SUCCINATE
Active Ingredient Strength200 mg/1
Pharm ClassesAdrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 55111-469-01

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-469-01)
Marketing Start Date2012-09-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55111-469-01 [55111046901]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-09-10

NDC 55111-469-79 [55111046979]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-09-10

NDC 55111-469-30 [55111046930]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-09-10

NDC 55111-469-78 [55111046978]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-09-10

NDC 55111-469-60 [55111046960]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-09-10

NDC 55111-469-05 [55111046905]

Metoprolol succinate TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA078889
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-09-10

Drug Details

Active Ingredients

IngredientStrength
METOPROLOL SUCCINATE200 mg/1

OpenFDA Data

SPL SET ID:71c1d33e-be6f-6d59-b715-45075445891a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 866419
  • 866412

    • Pharmacological Class

    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]
    • Adrenergic beta-Antagonists [MoA]
    • beta-Adrenergic Blocker [EPC]

    Medicade Reported Pricing

    55111046905 METOPROLOL SUCC ER 200 MG TAB

    Pricing Unit: EA | Drug Type:

    55111046901 METOPROLOL SUCC ER 200 MG TAB

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Metoprolol succinate" or generic name "Metoprolol Succinate"

    NDCBrand NameGeneric Name
    0378-4595Metoprolol Succinatemetoprolol succinate
    0378-4596Metoprolol Succinatemetoprolol succinate
    0378-4597Metoprolol Succinatemetoprolol succinate
    0378-4598Metoprolol Succinatemetoprolol succinate
    0527-2600METOPROLOL SUCCINATEMetoprolol succinate
    0527-2601METOPROLOL SUCCINATEMetoprolol succinate
    0527-2602METOPROLOL SUCCINATEMetoprolol succinate
    0527-2603METOPROLOL SUCCINATEMetoprolol succinate
    0615-6589METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-6597METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-6598METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-7530METOPROLOL SUCCINATEMETOPROLOL SUCCINATE
    0615-7823Metoprolol succinateMetoprolol succinate
    0615-7824Metoprolol succinateMetoprolol succinate
    0615-7825Metoprolol succinateMetoprolol succinate
    0615-8024METOPROLOL SUCCINATEMetoprolol succinate
    0615-8025METOPROLOL SUCCINATEMetoprolol succinate
    0904-6322Metoprolol succinateMetoprolol succinate
    0904-6323Metoprolol succinateMetoprolol succinate
    0904-6324Metoprolol succinateMetoprolol succinate
    68001-121Metoprolol succinateMetoprolol succinate
    68001-122Metoprolol succinateMetoprolol succinate
    68001-120Metoprolol succinateMetoprolol succinate
    68001-357Metoprolol SuccinateMetoprolol Succinate
    68001-358Metoprolol SuccinateMetoprolol Succinate
    68001-360Metoprolol SuccinateMetoprolol Succinate
    68001-119Metoprolol succinateMetoprolol succinate
    68001-356Metoprolol SuccinateMetoprolol Succinate
    68071-1913Metoprolol SuccinateMetoprolol Succinate
    68071-1922Metoprolol succinateMetoprolol succinate
    68071-1921Metoprolol succinateMetoprolol succinate
    68071-1923Metoprolol SuccinateMetoprolol Succinate
    68071-2191Metoprolol succinateMetoprolol succinate
    68071-4074Metoprolol SuccinateMetoprolol Succinate
    68071-4377Metoprolol SuccinateMetoprolol Succinate
    68071-4572Metoprolol SuccinateMetoprolol Succinate
    68071-4363Metoprolol SuccinateMetoprolol Succinate
    68071-4351Metoprolol SuccinateMetoprolol Succinate
    68084-666Metoprolol succinateMetoprolol succinate
    68084-659Metoprolol succinateMetoprolol succinate
    68084-673Metoprolol succinateMetoprolol succinate
    68151-1840Metoprolol succinateMetoprolol succinate
    68258-6019Metoprolol SuccinateMetoprolol Succinate
    68382-566metoprolol succinatemetoprolol succinate
    68382-567metoprolol succinatemetoprolol succinate
    68382-564metoprolol succinatemetoprolol succinate
    68382-565metoprolol succinatemetoprolol succinate
    68645-479Metoprolol succinateMetoprolol succinate
    68645-478Metoprolol succinateMetoprolol succinate
    68645-477Metoprolol succinateMetoprolol succinate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.